Return to homepagePandemic Pact

Broad-Spectrum Antiviral Effects and Immune Regulation Mechanisms of Cold Atmospheric Plasma Based on Immunotheranostics

  • Funded by National Health and Medical Research Council (NHMRC)
  • Total publications:0 publications

Grant number: GA537260

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2026
    2029

  • Known Financial Commitments (USD)

    $530,002.46

  • Funder

    National Health and Medical Research Council (NHMRC)

  • Principal Investigator

    N/A

  • Research Location

    Australia

  • Lead Research Institution

    Queensland University of Technology

  • Research Priority Alignment

    N/A

  • Research Category

    N/A

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Respiratory viruses like influenza and COVID-19 keep evolving, making treatments less effective. We’re engineering a new treatment approach using Cold Atmospheric Plasma (CAP), an accessible drug-free technology that kills viruses and boosts the body's natural defences. Unlike vaccines, CAP works regardless of new mutations that may occur. Our research will fine-tune CAP and uncover how it strengthens immunity, paving the way for a fast, broad antiviral solution to improve global health.